MedTrace Logo

Diabetes Mellitus and Inflammatory Bowel Disease

NCT04105348 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2019-10-01

No results posted yet for this study

Summary

Diabetes mellitus is a hyperglycemic metabolic disorder due to insulin deficiency or resistance at its receptors, leads to impaired glucose metabolism and multi-organ affection; (optic, peripheral neurological, cardiovascular and renal).

Conditions

  • Inflammatory Bowel Diseases

Interventions

DIAGNOSTIC_TEST

HbA1c

patients with raised investigations will be included in group 1 patients with normal investigations will be included in group 2

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2021-06-30
Completion
2021-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04105348 on ClinicalTrials.gov